Skip to content

BD BBL™ Sabouraud Dextrose Agar with Chloramphenicol Slants 221825Recalls & reported problems

Becton, Dickinson And Company · BD BBL™ Sabouraud Dextrose Agar with Chloramphenicol Slants, Carton of 100 size A tubes · Class 1

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 30382902218259), received between Jun 2, 2021 and Sep 19, 2023 — classified as 3 malfunctions.

The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Incorrect, Inadequate or Imprecise Result or Readings3

Patient problems

  • No Clinical Signs, Symptoms or Conditions3

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 19, 2023Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    IT WAS REPORTED THAT WHILE USING BD BBL¿ SABOURAUD DEXTROSE AGAR SLANTS WITH CHLORAMPHENICOL THAT THERE WAS OVERGROWTH. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: SABOURAUD TUBES FOR DERMATOPHYTE-TYPE FUNGI GROWN, QUITE FREQUENTLY SHOW BACTERIAL OVERGROWTH. SABOURAUD DEXTROSE CHLORAMPHENICOL TUBES FOR THE DETECTION OF THE GROWTH OF DERMATOPHYTE-TYPE FUNGI, QUITE FREQUENTLY PRESENT BACTERIAL OVERGROWTH A FEW DAYS AFTER BEING INCUBATED, SO THE ISOLATED CULTURE OF THE FUNGI IS DONE MORE DIFFICULT AND DELAYS THE ISSUANCE OF RESULTS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17778263 ↗
  • MalfunctionJul 6, 2021Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    IT WAS REPORTED THAT WHILE USING BD BBL¿ SABOURAUD DEXTROSE AGAR SLANTS WITH CHLORAMPHENICOL ATYPICAL GROWTH WAS OBSERVED BY THE LABORATORY PERSONNEL. THE CUSTOMER STATED RESULTS WERE NOT REPORTED OUT SO THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: " UNEXPECTED GROWTH OF BACTERIA. DOES NOT INHIBIT GROWTH ".

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12124190 ↗
  • MalfunctionJun 2, 2021Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    IT WAS REPORTED THAT PRIOR TO USE WITH BD BBL¿ SABOURAUD DEXTROSE AGAR SLANTS WITH CHLORAMPHENICOL 30 PLATES HAD BACTERIAL CONTAMINATION. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER, TRANSLATED FROM SPANISH TO ENGLISH: TUBES ARRIVED AT THE LAB WITH BACTERIA GROWTH. "GOOD MORNING, WE'VE HAD BACTERIAL CONTAMINATION IN THE DERMATOPHYTE CULTURE MEDIA."

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11922065 ↗

Other CULTURE MEDIA, SELECTIVE AND DIFFERENTIAL devices

All CULTURE MEDIA, SELECTIVE AND DIFFERENTIAL devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page